W. Timothy Garvey, MD
Nutrition Sciences at the University
Biography & Research Background
W. Timothy Garvey, MD is a professor in the Department of Nutrition Sciences at the University of Alabama at Birmingham. He served as principal investigator for the Phase 3 REDEFINE program evaluating cagriniltide combined with semaglutide (CagriSema) in a 3,417-participant trial. He is an author of REDEFINE-program publications. W. Timothy Garvey is being referenced as one of the leading scientists involved in cagriniltide research. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of this product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure US Peptide and this doctor.
External Profiles
Cited In These Research Profiles (1)
W. Timothy Garvey, MD is referenced as a leading researcher in the following peptide research profiles on Pure U.S. Peptides:
W. Timothy Garvey, MD is being referenced as one of the leading scientists involved in the research and development of the peptides listed above. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of any product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure U.S. Peptides and this researcher. The purpose of citing the researcher is to acknowledge, recognize, and credit the exhaustive research and development efforts conducted by the scientists studying these peptides.